...
首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery
【24h】

Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery

机译:靶向治疗和免疫疗法治疗的黑素瘤患者的存活率在放射外科脑转移后进行系统前期控制

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Targeted therapy (TT) and immunotherapies (ITs) have dramatically improved survival in metastatic melanoma (MM). However, their efficacy on brain metastasis (BM) remains limited and poorly documented.
机译:背景:靶向治疗(TT)和免疫治疗(其)在转移性黑色素瘤(mm)中显着改善了存活率。 然而,它们对脑转移(BM)的疗效仍然有限,记录不足。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号